Takeshi Watanabe Selected Research

Adenocarcinoma

1/2022	Protruding structures with high expression of LGR5 are formed during regrowth phase after chemo-treatment in xenograft model of colorectal adenocarcinoma.
1/2020	A Rare Case of Moderately Differentiated Adenocarcinoma With PD-L1 Overexpression and a Heterogeneous LELC Component in the Ascending Colon.
4/2017	Immunohistochemical characterization of urethane-induced lung tumors in CB6F1-Tg rasH2 mice.
10/2003	Differential chemokine, chemokine receptor, cytokine and cytokine receptor expression in pulmonary adenocarcinoma: diffuse down-regulation is associated with immune evasion and brain metastasis.
5/2003	Expression of apoptosis-associated protein RCAS1 in macrophages of histiocytic necrotizing lymphadenitis.
1/2003	Expression and diagnostic evaluation of the human tumor-associated antigen RCAS1 in pancreatic cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takeshi Watanabe Research Topics

Disease

31	Neoplasms (Cancer) 01/2022 - 01/2002
10	Inflammation (Inflammations) 01/2022 - 06/2006
7	Neoplasm Metastasis (Metastasis) 01/2022 - 10/2003
7	Carcinoma (Carcinomatosis) 01/2020 - 06/2002
6	Adenocarcinoma 01/2022 - 01/2003
5	Ischemia 01/2022 - 01/2019
5	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2011 - 05/2008
4	Necrosis 04/2022 - 04/2015
4	Rheumatoid Arthritis 02/2016 - 01/2005
3	Pain (Aches) 05/2022 - 06/2002
3	Reperfusion Injury 01/2022 - 07/2015
3	Colonic Neoplasms (Colon Cancer) 09/2021 - 12/2012
3	Otitis Media 02/2021 - 01/2017
3	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 02/2021 - 01/2017
3	Hemorrhage 01/2021 - 09/2014
3	Bacterial Infections (Bacterial Infection) 01/2011 - 08/2004
3	Infections 11/2010 - 02/2002
3	Hepatocellular Carcinoma (Hepatoma) 12/2009 - 08/2005
3	Stomach Neoplasms (Stomach Cancer) 05/2006 - 12/2002
3	Body Weight (Weight, Body) 01/2006 - 12/2002
3	Hypersensitivity (Allergy) 03/2003 - 05/2002
2	Hypoxia (Hypoxemia) 04/2022 - 10/2020
2	Thrombosis (Thrombus) 01/2021 - 01/2006
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 07/2003
2	Burning Mouth Syndrome (Syndrome, Burning Mouth) 01/2019 - 09/2018
2	Hearing Loss (Hearing Impairment) 10/2018 - 01/2017
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 07/2018 - 01/2013
2	Colitis 07/2018 - 01/2013
2	Poisoning 12/2017 - 10/2014
2	Adenoma (Adenomas) 04/2017 - 06/2013
2	Lung Neoplasms (Lung Cancer) 03/2015 - 01/2002
2	Atopic Dermatitis (Atopic Eczema) 06/2014 - 01/2014
2	Stroke (Strokes) 07/2013 - 09/2002
2	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 09/2012 - 12/2004
2	Ovarian Neoplasms (Ovarian Cancer) 09/2012 - 03/2007
2	Cysts 06/2011 - 12/2009
2	Werner Syndrome (Werner's Syndrome) 02/2011 - 04/2009
2	Sepsis (Septicemia) 01/2011 - 08/2004
2	Cystitis 12/2009 - 10/2009
2	Malaria 04/2009 - 02/2008
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 08/2006 - 10/2005
2	Pneumonia (Pneumonitis) 06/2006 - 08/2004
2	Obesity 01/2006 - 09/2004
2	Overactive Urinary Bladder (Overactive Bladder) 05/2005 - 08/2004
2	Cholangiocarcinoma 10/2003 - 06/2002
2	Sneezing 08/2002 - 05/2002

Drug/Important Bio-Agent (IBA)

20	Histamine (Histamine Dihydrochloride)FDA Link 01/2015 - 04/2002
19	AntigensIBA 03/2007 - 01/2002
11	Proteins (Proteins, Gene)FDA Link 07/2018 - 06/2002
8	Histamine Receptors (Histamine Receptor)IBA 09/2013 - 07/2002
7	CytokinesIBA 02/2016 - 10/2003
5	Histidine DecarboxylaseIBA 11/2009 - 06/2003
4	Pharmaceutical PreparationsIBA 05/2022 - 08/2004
4	Biomarkers (Surrogate Marker)IBA 12/2021 - 12/2006
4	ChemokinesIBA 07/2018 - 10/2003
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2018 - 08/2004
4	EnzymesIBA 10/2014 - 01/2003
4	Biological ProductsIBA 12/2012 - 12/2006
4	Messenger RNA (mRNA)IBA 06/2006 - 09/2004
4	Monoclonal AntibodiesIBA 10/2003 - 01/2002
3	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 02/2021 - 01/2017
3	Glucose (Dextrose)FDA LinkGeneric 12/2017 - 03/2003
3	Peptides (Polypeptides)IBA 01/2017 - 08/2005
3	CollagenIBA 03/2015 - 01/2006
3	Streptozocin (Streptozotocin)FDA Link 12/2009 - 03/2002
3	AminesIBA 04/2009 - 03/2003
3	Cholinergic Antagonists (Anticholinergics)IBA 12/2007 - 08/2004
3	Fas Ligand Protein (Fas Ligand)IBA 06/2005 - 01/2003
3	Histamine H1 Receptors (Histamine H1 Receptor)IBA 09/2004 - 05/2002
2	Myeloblastin (Proteinase 3)IBA 02/2021 - 01/2017
2	Peroxidase (Myeloperoxidase)IBA 02/2021 - 01/2017
2	Amitriptyline (Elavil)FDA LinkGeneric 01/2019 - 09/2018
2	Chemokine ReceptorsIBA 07/2018 - 10/2003
2	LigandsIBA 07/2018 - 01/2002
2	SolutionsIBA 10/2014 - 05/2002
2	Small Interfering RNA (siRNA)IBA 05/2013 - 08/2005
2	DNA (Deoxyribonucleic Acid)IBA 09/2012 - 10/2003
2	Scavenger Receptors (Scavenger Receptor)IBA 06/2011 - 12/2009
2	RecQ HelicasesIBA 02/2011 - 04/2009
2	Telomerase (Telomerase Reverse Transcriptase)IBA 02/2011 - 04/2009
2	Superoxide Dismutase-1IBA 01/2011 - 05/2008
2	Cimetidine (Biomet)FDA LinkGeneric 01/2011 - 08/2006
2	GlypicansIBA 12/2009 - 08/2009
2	VimentinIBA 12/2009 - 10/2005
2	Amino Acids FDA Link 10/2009 - 03/2004
2	ChitinasesIBA 05/2009 - 04/2003
2	Immunoglobulin G (IgG)IBA 07/2008 - 12/2004
2	oxybutynin (Tavor)FDA LinkGeneric 12/2007 - 08/2004
2	Complementary DNA (cDNA)IBA 05/2006 - 12/2002
2	HLA-A*02:01 antigenIBA 05/2006 - 08/2005
2	LipopolysaccharidesIBA 09/2004 - 08/2004
2	talabostatIBA 08/2004 - 09/2003
2	Tumor Biomarkers (Tumor Markers)IBA 10/2003 - 01/2002

Therapy/Procedure

9	Therapeutics 01/2022 - 08/2004
4	Immunotherapy 01/2018 - 08/2005
3	Drug Therapy (Chemotherapy) 01/2022 - 12/2017
3	Ligation 10/2020 - 01/2011
3	Oral Administration 01/2018 - 08/2004
2	Colectomy 09/2021 - 01/2020
2	Nephrectomy 11/2011 - 12/2002